Indeed, NFκB knockdown resulted in a significant decrease in GLI1 expression, and GLI1 knockdown resulted in decreased claudin-low breast cancer and EMT cell lines’ tumorigenicity. The gene discussed is NFKB1; the disease is breast carcinoma.